Delineate

Winter 2025Active

Agents for Accelerated Clinical Trial Design

Save

Delineate

Winter 2025Active

Agents for Accelerated Clinical Trial Design

Save

Company details

Delineate is building AI agents to design better clinical trials faster.

This is a $10B dollar market, where saving even 1 day along the process is equal to $1-5M in revenue potential.

We process existing clinical trial research into specialized datasets saving scientists months of effort.

Delineate is working with two of the largest pharmaceutical companies. With one of our customers, we are helping them get to the next phase of trials faster by creating the largest dataset on a drug class ever constructed.

Location

Boston, MA, USA; Remote

Founded

Unknown

Request the Delineate report.

Delineate has no report yet. Sign in with your email to request one.